Warren, NJ – November 29, 2018 – Knowledgent, the data intelligence company, announced today that it has launched its Intelligent Trial Planning (ITP) platform on the new AWS Marketplace for Machine Learning.
Patient Recruitment delays are increasing clinical trial length within many Therapeutic Areas for the Life Sciences industry. This means increases to Research & Development (R&D) costs and decreases to product revenue.
Knowledgent’s ITP platform enables clinical researchers to understand the timeline impact of Inclusion/Exclusion criteria on their trials. ITP uses Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning models to forecast study enrollment and provide decision support through a highly accurate and automated process.
“ITP is revolutionizing the way Life Sciences companies forecast enrollment for clinical trials,” said Shail Jain, Chief Executive Partner, Knowledgent. “The platform creates a significant reduction in both the cost and length of trials for our clients.”
ITP is currently available on the AWS Marketplace for Machine Learning for four different indications: Inflammation & Immunology, Solid Tumor, Lymphoma, and Myeloid. To learn more please visit the AWS Marketplace for Machine Learning at https://aws.amazon.com/marketplace and search “ITP”.
Knowledgent is a data intelligence company that enables enterprises to become digital and intelligent by innovating in and through data for the healthcare and financial services industries. For more information, visit knowledgent.com.